Decision-Making and Quality of Life Surrounding Hematologic Disease and Gene Therapy

Clinical trial NCT06664541 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT06664541
Sponsor: Georgetown University
Status: ENROLLING_BY_INVITATION
Study type: OBSERVATIONAL

Transfusion Dependent Beta Thalassemia Sickle Cell Disease

Start date: 2024-10-01
Primary completion: 2026-10-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.